Browse the evidence

Calorie restriction extends lifespan in yeast by acting as a mild biological stressor that activates the Sir2 deacetylase, rather than by simply slowing metabolism or reducing oxidative damage.

Calorie restriction extends lifespan in yeast by activating Sir2 through a mild stress response. This suggests that mild, intermittent reductions in caloric intake may trigger similar survival pathways in humans, potentially delaying age-related diseases.

Rapid weight gain in infancy, often driven by high protein intake in infant formula, is associated with an increased risk of later obesity and adverse metabolic outcomes.

If using infant formula, consider one with lower protein content, as it is associated with a lower risk of obesity at age 14-16 years. Breastfeeding is also protective. Monitor your infant's growth curve to ensure steady, not rapid, weight gain.

Methionine restriction extends chronological lifespan in yeast by inducing autophagy, which subsequently stimulates vacuolar acidification; this pathway is strictly dependent on functional autophagy genes (ATG5, ATG7, ATG8).

In yeast models, restricting the amino acid methionine significantly extends lifespan by triggering a cellular cleanup process called autophagy, which requires the vacuole to become more acidic. This effect is lost if the autophagy genes are disabled. While this is a yeast model, it suggests that amino acid composition, specifically methionine levels, may play a critical role in triggering cellular maintenance pathways relevant to aging.

Homozygosity for the APOC3 -641C allele (rs2542052) is associated with lower serum APOC3 levels, favorable lipoprotein profiles, greater insulin sensitivity, lower hypertension prevalence, and significantly increased survival rates in Ashkenazi Jewish centenarians and their offspring.

This research highlights a specific genetic variant (APOC3 -641C) linked to better heart health and longer life in Ashkenazi Jewish populations. While you cannot change your DNA, this finding underscores the importance of maintaining healthy lipid levels, blood pressure, and insulin sensitivity, as these are the physiological pathways through which this genetic advantage operates. For those with this genotype, these health metrics may be even more critical to preserve.

Orexin deficiency is the primary cause of narcolepsy, characterized by a loss of orexin-containing neurons in the lateral hypothalamus.

For individuals with narcolepsy, the underlying cause is often the loss of orexin-producing neurons. Treatments may focus on managing symptoms or potentially replacing orexin signaling, as the system is crucial for maintaining wakefulness.

Current standard laboratory nucleic acid amplification tests (NAATs) are more accurate and cost-effective than rapid point-of-care tests (POCTs) for detecting genital chlamydia infection.

For chlamydia testing, laboratory-based nucleic acid amplification tests (NAATs) remain the gold standard because they are more accurate and cost-effective than rapid point-of-care tests. While rapid tests provide faster results, they miss more infections and cost more to the healthcare system. Providers should prioritize NAATs for diagnostic accuracy, though rapid tests may be considered in specific contexts where they significantly increase testing uptake.

Domestic economic development, urbanization, and women's empowerment drive global increases in BMI, whereas economic and cultural globalization do not significantly predict weight gain.

Focus on understanding how your country's economic development, urbanization, and social changes (like women's workforce participation) impact your community's health. Simply opening markets to global goods does not automatically cause obesity; domestic socio-economic transitions are the stronger drivers.

Exenatide treatment significantly reduces dopamine transporter (DAT) availability in the striatum, caudate, and putamen in patients with Alcohol Use Disorder.

Exenatide changes the brain's dopamine transporter levels in key reward areas, which may help compensate for the dopamine deficits seen in chronic alcohol use. This is a biological mechanism, not a direct measure of drinking behavior.

A high-fat, ketogenic diet causes severe hepatic insulin resistance in mice, driven by increased hepatic diacylglycerol (DAG) content and subsequent PKCε activation, despite preventing weight gain and increasing energy expenditure.

This study in mice shows that a very high-fat, near-zero carbohydrate diet can cause liver insulin resistance and fatty liver disease, even if it helps prevent weight gain. While popular for weight loss, this suggests potential risks for liver health that should be monitored, especially in individuals predisposed to metabolic issues.

Epigenetic aging initiates early in life upon the loss of pluripotency during differentiation, and the epigenetic age of a tissue is largely determined by the composition of stem cells versus differentiated cells.

Epigenetic aging begins when cells lose their stem-like pluripotency and start differentiating. The overall epigenetic age of a tissue reflects the balance of young stem cells and older differentiated cells. Maintaining a healthy stem cell pool may help keep tissue-level epigenetic age lower.

Natural aging in mice correlates genome-wide with progeroid (accelerated) aging models, but not with long-lived models, indicating that natural aging resembles biological age markers of damage rather than longevity assurance.

Your body's gene expression as you age naturally looks more like accelerated aging (progeria) than like the healthy, long-lived state. This suggests that standard aging involves a 'survival' response to damage. Interventions that extend lifespan (like calorie restriction) may work by decoupling this survival response from the aging process.

Pharmacological activation of AMP-activated protein kinase (AMPK) via AICAR increases PGC-1α promoter activity and mRNA expression in skeletal muscle cells by enhancing the DNA binding of the transcription factor USF-1 to the EBox element of the PGC-1α promoter.

This research explains why endurance exercise and high-intensity efforts (which activate AMPK) are effective at improving mitochondrial health. The mechanism involves AMPK turning on the PGC-1α gene via specific DNA binding sites. To leverage this, engage in activities that create an energy deficit in muscle cells (like sustained aerobic exercise or high-intensity intervals), as this naturally activates the AMPK pathway described here.

Long-term administration of the GLP-1 receptor agonist exendin-4 (Ex4) promotes pancreatic beta-cell growth and survival, but this specific trophic effect is strictly dependent on Insulin Receptor Substrate 2 (Irs2) signaling; without Irs2, Ex4 cannot prevent beta-cell loss or diabetes progression.

This research clarifies that while GLP-1 drugs (like exendin-4/exenatide) effectively stimulate insulin release in the short term regardless of Irs2 status, their ability to actually grow or save beta cells long-term relies on a functional Irs2 signaling pathway. For patients with compromised Irs2 signaling, these drugs may improve blood sugar control via remaining beta cells but may not halt beta-cell loss or regenerate mass.

Tight glucose control (targeting 4.4-6.1 mmol/L) increases mortality in critically ill patients compared to a less strict target (less than 10 mmol/L), and optimal targets may vary based on diabetes status.

Do not use tight glucose control (targeting 4.4-6.1 mmol/L) in critically ill patients. Instead, aim for a less strict target (less than 10 mmol/L) to avoid the increased mortality risk associated with tight control. Consider individualizing targets based on diabetes status.

Inhibition of mTORC1 by rapamycin extends lifespan in multiple species by enhancing autophagy and mitophagy, thereby maintaining mitochondrial homeostasis.

Rapamycin extends lifespan in model organisms by boosting cellular cleanup (autophagy/mitophagy). While effective, chronic use has side effects. Dietary restriction also activates this pathway, offering a natural way to achieve similar benefits without pharmaceutical intervention.

Dietary fat intake does not activate brain PPARα to reverse hypophagia in mice with hypothalamic FAS inactivation, indicating that de novo synthesized fatty acids are required for this specific signaling pathway.

This study suggests that the brain's ability to regulate appetite via PPARα depends on fatty acids made internally by the enzyme FAS, not just those from your diet. This highlights the complexity of brain metabolism and why simply changing dietary fat might not fix all appetite regulation issues.

Leptin receptors are localized in specific regions of the human brain, including the hypothalamus, substantia nigra, and cerebellum, confirming the anatomical basis for leptin's role in central nervous system regulation.

This research confirms that leptin, a hormone produced by fat cells, communicates directly with your brain (specifically the hypothalamus) to help regulate energy balance and appetite. Understanding this link is crucial for grasping how body weight regulation works biologically.

During early critical illness, intramuscular lipid delivery (from enteral or parenteral nutrition) is bioenergetically inert and does not contribute to ATP content or muscle mass preservation.

In the first week of critical illness, standard lipid-based nutrition does not appear to fuel muscle energy or prevent muscle loss because the muscle's mitochondria are dysfunctional. This suggests that early lipid delivery may be ineffective for muscle preservation in this specific acute phase.

Central nervous system (CNS) inflammation, specifically via IL-1β signaling, induces skeletal muscle atrophy through the activation of the hypothalamic-pituitary-adrenal (HPA) axis and subsequent glucocorticoid release, independent of direct peripheral cytokine action on muscle.

In chronic inflammatory conditions, muscle loss is driven significantly by the brain's response to inflammation (via the HPA axis and stress hormones), not just by the inflammation hitting the muscle directly. This suggests that interventions targeting the central inflammatory response or stress hormone pathways may be necessary to prevent muscle wasting, rather than just focusing on local muscle nutrition or exercise.

FOXO3a variants are associated with increased human life span, with the minor allele conferring a higher odds of longevity (OR 2.75) in centenarians of Japanese descent, and this association has been replicated in diverse populations including German, Italian, Chinese, and Danish cohorts.

FOXO3a is a gene linked to longevity, particularly in the insulin/IGF-1 signaling pathway. While you cannot change your genes, understanding this pathway highlights the importance of metabolic health. Interventions that modulate insulin sensitivity and cellular stress response (like exercise and balanced nutrition) may leverage this genetic potential.

In patients with ileum resected short bowel syndrome and a preserved colon, endogenous plasma concentrations of GLP-1 and GLP-2 are significantly elevated compared to healthy controls, contributing to functional intestinal adaptation.

For patients with extensive small bowel removal, keeping the colon is physiologically critical. The colon's L cells secrete high levels of GLP-1 and GLP-2 when nutrients reach them, which slows digestion and promotes intestinal growth. This natural hormonal response is a key reason why patients with a preserved colon have better outcomes than those without.

Inhibition of sphingolipid synthesis (specifically via SPT inhibition by myriocin or CerS inhibition by fumonisin B1) extends lifespan in model organisms like yeast and C. elegans, suggesting that reducing ceramide production can delay aging.

Research in simple organisms shows that reducing the production of certain lipids (sphingolipids) can extend lifespan. This suggests that metabolic pathways involving lipid synthesis are key regulators of aging. For humans, this points to the importance of metabolic health and lipid balance, though direct application of inhibitors like myriocin is not currently a standard human intervention.

Inhibition of cyclooxygenase (COX) activity prevents the induction of UCP1 in white adipose tissue (WAT), thereby reducing diet-induced thermogenesis and promoting increased adiposity.

This research suggests that chronic use of COX inhibitors (like indomethacin, and potentially NSAIDs like ibuprofen) might interfere with your body's ability to burn fat through 'browning' of white fat, especially if you are not exercising in cold environments. For most people, occasional use is fine, but if you are trying to maximize metabolic efficiency, be aware that these drugs might blunt a specific fat-burning pathway.

In severely burned patients, delivering caloric intake exceeding 1.2 times resting energy expenditure (REE) increases fat mass accretion without attenuating the erosion of lean body mass.

For severe burn patients, feeding significantly above measured energy needs (specifically >1.2x REE) will not save muscle; it will only add fat. Since muscle loss is driven by the injury's metabolic response rather than just caloric deficit, excessive feeding is counterproductive for body composition, adding fat without preserving lean mass.